Shanghai Frontiers Science Center for Biomacromolecules and Precision Medicine of ShanghaiTech University, and a Career Award for Medical Scientists from the Burroughs Wellcome Fund
The study was profiled on December 3 in Healios publication Endocrine Today
Tirzepatide sold as Zepbound for weight management and Mounjaro for type 2 diabetes is a once-weekly injectable medication that activates both GLP-1 and GIP receptors to support meaningful appetite control and weight loss
"Optimizing Needle Gauge Selection for Subcutaneous Injections: A Comprehensive Review." Journal of Diabetes Technology & Therapeutics, 24(5), 287-301
Mandarino LJ, Printz RL, Cusi KA, et al
Improved metabolic health: Reductions in triglycerides, improvements in lipid profiles, and better metabolic markers